Ítem
Solo Metadatos

Guidelines for the diagnosis and management of neuropathic pain: Consensus of a group of latin american experts

dc.creatorAcevedo, Juan Carlosspa
dc.creatorAmaya, Abrahamspa
dc.creatorCasasola, Oscar de Leónspa
dc.creatorChinchilla, Nelsonspa
dc.creatorDe Giorgis, Marcelospa
dc.creatorFlorez, Sandraspa
dc.creatorGenis, Miguel Angelspa
dc.creatorGomez-Barrios, Juan Vicentespa
dc.creatorHernandez-Castro, John-Jairo
dc.creatorIbarra, Eduardospa
dc.creatorMoreno, Carlos B
dc.creatorOrrillo, Enriquespa
dc.creatorPasternak, Danilospa
dc.creatorRomero, Sabinaspa
dc.creatorVallejo, Marianaspa
dc.creatorVelasco, Maritzaspa
dc.creatorVillalobos, Albertospa
dc.date.accessioned2020-05-25T23:56:23Z
dc.date.available2020-05-25T23:56:23Z
dc.date.created2009spa
dc.description.abstractThese consensus guidelines have been developed by a group of Latin American experts in pain management, to point out patterns and make practical recommendations to guide the diagnosis, identify warning signs (yellow and red flags), and establish comprehensive medical management (pharmacologic and nonpharmacologic treatment) and monitoring plans for patients enduring neuropathic pain. From the viewpoint of pharmacologic management, drugs are classified into groups according to efficacy, availability/accessibility, and safety criteria. Drugs are recommended for use depending on the disease and particular circumstances of each patient, with an approach that favors multimodal treatment while taking into consideration the idiosyncrasies of medical practice in Latin America.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1080/15360280903098572
dc.identifier.issn15360288
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/22413
dc.language.isoengspa
dc.relation.citationEndPage281
dc.relation.citationIssueNo. 3
dc.relation.citationStartPage261
dc.relation.citationTitleJournal of Pain and Palliative Care Pharmacotherapy
dc.relation.citationVolumeVol. 23
dc.relation.ispartofJournal of Pain and Palliative Care Pharmacotherapy, ISSN:15360288, Vol.23, No.3 (2009); pp. 261-281spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-70849132841&doi=10.1080%2f15360280903098572&partnerID=40&md5=5ac15d2819c5919b4a514cb7ed378a04spa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordAmitriptylinespa
dc.subject.keywordAnalgesic agentspa
dc.subject.keywordBuprenorphinespa
dc.subject.keywordCannabinoidspa
dc.subject.keywordCarbamazepinespa
dc.subject.keywordCytidine phosphatespa
dc.subject.keywordDesipraminespa
dc.subject.keywordDuloxetinespa
dc.subject.keywordFentanylspa
dc.subject.keywordFluoxetinespa
dc.subject.keywordGabapentinspa
dc.subject.keywordImipraminespa
dc.subject.keywordKetaminespa
dc.subject.keywordLamotriginespa
dc.subject.keywordLidocainespa
dc.subject.keywordMethadonespa
dc.subject.keywordMorphinespa
dc.subject.keywordNabilonespa
dc.subject.keywordNonsteroid antiinflammatory agentspa
dc.subject.keywordNortriptylinespa
dc.subject.keywordOpiatespa
dc.subject.keywordOxycodonespa
dc.subject.keywordPregabalinspa
dc.subject.keywordThioctic acidspa
dc.subject.keywordTramadolspa
dc.subject.keywordTricyclic antidepressant agentspa
dc.subject.keywordUridine phosphatespa
dc.subject.keywordVenlafaxinespa
dc.subject.keywordAcupuncturespa
dc.subject.keywordAdultspa
dc.subject.keywordArticlespa
dc.subject.keywordClinical protocolspa
dc.subject.keywordConsensusspa
dc.subject.keywordControlled studyspa
dc.subject.keywordCreatinine blood levelspa
dc.subject.keywordDiagnostic testspa
dc.subject.keywordDisease coursespa
dc.subject.keywordDrug bioavailabilityspa
dc.subject.keywordDrug dose titrationspa
dc.subject.keywordDrug efficacyspa
dc.subject.keywordDrug half lifespa
dc.subject.keywordDrug releasespa
dc.subject.keywordDrug safetyspa
dc.subject.keywordDrug tolerabilityspa
dc.subject.keywordEdemaspa
dc.subject.keywordHumanspa
dc.subject.keywordInvasive procedurespa
dc.subject.keywordLow drug dosespa
dc.subject.keywordMedical expertspa
dc.subject.keywordMedical practicespa
dc.subject.keywordNeurologic examinationspa
dc.subject.keywordNeuropathic painspa
dc.subject.keywordPain assessmentspa
dc.subject.keywordPhysical examinationspa
dc.subject.keywordPhytotherapyspa
dc.subject.keywordPractice guidelinespa
dc.subject.keywordQuality of lifespa
dc.subject.keywordRecommended drug dosespa
dc.subject.keywordRehabilitation carespa
dc.subject.keywordSide effectspa
dc.subject.keywordSouth and central americaspa
dc.subject.keywordSymptomspa
dc.subject.keywordTreatment planningspa
dc.subject.keywordUnspecified side effectspa
dc.subject.keywordXerostomiaspa
dc.subject.keywordAnalgesicsspa
dc.subject.keywordHumansspa
dc.subject.keywordLatin americaspa
dc.subject.keywordNeuralgiaspa
dc.subject.keywordPain measurementspa
dc.subject.keywordPractice guidelines as topicspa
dc.subject.keywordConsensusspa
dc.subject.keywordGuidelinesspa
dc.subject.keywordLatin americaspa
dc.subject.keywordNeuropathic painspa
dc.titleGuidelines for the diagnosis and management of neuropathic pain: Consensus of a group of latin american expertsspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones